[en] OBJECTIVE: Atypical forms of hyperthyroidism represent a diagnostic challenge for clinicians. Struma ovarii is an ovarian teratoma and constitutes a rare cause of ectopic thyroidal hormonal production. We describe a case of struma ovarii that combined two different sources of hyperthyroidism in the same patient and report genetic studies in order to contribute a better understanding of the autonomy and tumorigenesis of the struma ovarii. CASE REPORT: A 73-year-old nulliparous woman presented a thyroid toxic adenoma that was successfully treated with 10 mCi radioiodine. Unexpectedly, a new onset of hyperthyroidism prompted us to look for a second etiology. A whole-body scan with (123)I detected a pelvic hyperfixation suggesting struma ovarii, and a thyroid differentiated left ovarian teratoma 3 cm in size was surgically removed. We screened for mutations of thyroid-stimulating hormone receptor and Gs-alpha protein genes, as these mutations are common in thyroid adenomas. We did not identify any mutations. Androgen receptor study demonstrated a monoclonal status. Comparative genomic hybridization did not reveal any chromosomal abnormality. However, loss of heterozygosity analysis showed several structural abnormalities, compared with the majority of benign ovarian teratomas, which show a normal karyotype. CONCLUSIONS: This is the first well-documented report of thyrotoxic struma ovarii revealed after treatment of a single thyroid toxic adenoma. We have shown in this case that struma ovarii originates from a single germ cell, and, albeit benign, this tumor presents several chromosomal abnormalities. Struma ovarii-induced hyperthyroidism is likely to be mediated by mechanisms different from those of the classical thyroid toxic adenoma.
Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinology and Metabolism Clinics of North America 1998 27 169-185.
Ayhan A, Yanik F, Tuncer R, Tuncer ZS & Ruacan S. Struma ovarii. International Journal of Gynaecology and Obstetrics 1993 42 143-146.
Vortmeyer AO, Devouassoux-Shisheboran M, Li G, Mohr V, Tavassoli F & Zhuang Z. Microdissection-based analysis of mature ovarian teratoma. American Journal of Pathology 1999 154 987-991.
Surti U, Hoffner L, Chakravarti A & Ferrell RE. Genetics and biology of human ovarian teratomas. I Cytogenetic analysis and mechanism of origin. American Journal of Human Genetics 1990 47 635-643.
de Roux N, Misrahi M, Chatelain N, Gross B & Milgrom E. Microsatellites and PCR primers for genetic studies and genomic sequencing of the human TSH receptor gene. Molecular and Cellular Endocrinology 1996 117 253-256.
Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. Journal of Clinical Endocrinology and Metabolism 1997 82 2695-2701.
Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H et al. Two G protein oncogenes in human endocrine tumors. Science 1990 249 655-659.
Allen RC, Zoghbi HY, Moseley AB, Roseblatt HM & Belmont JW. Methylation of HapII and HhaI sites near the polymorphic CAG repeat in the human androgen receptor gene correlates with X chromosome inactivation. American Journal of Human Genetics 1992 51 1229-1239.
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992 258 818-821.
Dunzendorfer T, de Las Morenas A, Kalir T & Levin RM. Struma ovarii and hyperthyroidism. Thyroid 1999 9 499-502.
Kempers R, Dockerty M, Hoffman D & Bartholomew L. Struma ovarii - ascitic, hyperthyroid and asymptomatic syndromes. Annals of Internal Medicine 1970 72 883-889.
Devaney K, Snyder R, Norris HJ & Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. International Journal of Gynaecological Pathology 1993 12 333-343.
Hamburger JI. Pitfalls in the laboratory diagnosis of atypical hyperthyroidism. Archives of Internal Medicine 1979 139 96-98.
Mimura Y, Kishida M, Masuyama H, Suwaki N, Kodama J, Otsuka F et al. Coexistence of Graves' disease and struma ovarii: case report and literature review. Endocrine Journal 2001 48 255-260.
Dremier S, Coppee F, Delange F, Vassart G, Dumont JE & Van Sande J. Thyroid autonomy: mechanism and clinical effects. Journal of Clinical Endocrinology and Metabolism 1996 81 4187-4193.
Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993 265 649-651.
Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G & Avvedimento VE. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. Journal of Clinical Endocrinology and Metabolism 1994 79 657-661.
Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA et al. Genetic alterations in thyroid hyperfunctioning adenomas. Journal of Clinical Endocrinology and Metabolism 1995 80 1347-1351.
Linder D & Power J. Further evidence for post-meiotic origin of teratomas in the human female. Annals of Human Genetics 1970 34 21-30.
Dahl N, Gustavson KH, Rune C, Gustavsson I & Pettersson U. Benign ovarian teratomas. An analysis of their cellular origin. Cancer Genetics and Cytogenetics 1990 46 115-123.
Patil SR, Kaiser-McCaw B, Hecht F, Linder D & Lovrien EW. Human benign ovarian teratomas: chromosomal and electrophoretic enzyme studies. Birth Defects 1978 14 297-301.
Carritt B, Parrington JM, Welch HM & Povey S. Diverse origins of multiple ovarian teratomas in a single individual. PNAS 1982 79 7400-7404.
Riopel MA, Spellerberg A, Griffin CA & Perlman EJ. Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. Cancer Research 1998 58 3105-3110.
Noumoff JS, LiVolsi VA, Deger RB, Montone KT & Faruqi SA. Chromosome analysis and comparison of the benign cystic and malignant squamous component of an ovarian teratoma. Cancer Genetics and Cytogenetics 2001 125 59-62.
Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E et al. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Genes Chromosomes Cancer 1997 20 234-242.
van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH et al. Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. International Journal of Cancer 1993 53 613-620.